| 000 | 01756 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250514051155.0 | ||
| 264 | 0 | _c20030408 | |
| 008 | 200304s 0 0 eng d | ||
| 022 | _a0007-1188 | ||
| 024 | 7 |
_a10.1038/sj.bjp.0704943 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aXi, Qi | |
| 245 | 0 | 0 |
_aInvolvement of T-type calcium channels in excitatory junction potentials in rat resistance mesenteric arteries. _h[electronic resource] |
| 260 |
_bBritish journal of pharmacology _cNov 2002 |
||
| 300 |
_a805-12 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdenosine Triphosphate _xanalogs & derivatives |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCalcium Channel Blockers _xpharmacology |
| 650 | 0 | 4 |
_aCalcium Channels, T-Type _xdrug effects |
| 650 | 0 | 4 | _aElectric Stimulation |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMesenteric Arteries _xdrug effects |
| 650 | 0 | 4 |
_aMibefradil _xpharmacology |
| 650 | 0 | 4 |
_aMuscle Contraction _xdrug effects |
| 650 | 0 | 4 |
_aNeuromuscular Junction _xdrug effects |
| 650 | 0 | 4 |
_aNicardipine _xpharmacology |
| 650 | 0 | 4 |
_aNickel _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aTetrodotoxin _xpharmacology |
| 650 | 0 | 4 |
_aVas Deferens _xdrug effects |
| 650 | 0 | 4 | _aVascular Resistance |
| 650 | 0 | 4 |
_aVasoconstriction _xdrug effects |
| 650 | 0 | 4 |
_aomega-Conotoxin GVIA _xpharmacology |
| 700 | 1 | _aZiogas, James | |
| 700 | 1 | _aRoberts, Jonathan A | |
| 700 | 1 | _aEvans, Richard J | |
| 700 | 1 | _aAngus, James A | |
| 773 | 0 |
_tBritish journal of pharmacology _gvol. 137 _gno. 6 _gp. 805-12 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.bjp.0704943 _zAvailable from publisher's website |
| 999 |
_c12219483 _d12219483 |
||